Glucagon-like peptide-1 receptor stimulation increases GFR and suppresses proximal reabsorption in the rat

American Journal of Physiology - Renal Physiology

Volumn 304, Issue 2, 2013, Pages

  Thomson, Scott C ^a   Kashkouli, Ali ^a   Singh, Prabhleen ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Exenatide; Glomerular filtration; Glucagon like peptide 1; Tubular reabsorption; Tubuloglomerular feedback

Indexed keywords

EXENDIN 4; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; TRANSFORMING GROWTH FACTOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIURESIS; DRUG EFFECT; DRUG INFUSION; GLOMERULUS FILTRATION RATE; HENLE LOOP; KIDNEY; KIDNEY FUNCTION; KIDNEY PERFUSION; KIDNEY PROXIMAL TUBULE; KIDNEY PROXIMAL TUBULE REABSORPTION; KIDNEY TUBULE ABSORPTION; KIDNEY TUBULOGLOMERULAR FEEDBACK; MALE; NEGATIVE FEEDBACK; NEPHRON; NONHUMAN; PRIORITY JOURNAL; PUNCH BIOPSY; RAT; SINGLE NEPHRON GLOMERULAR FILTRATION RATE; URINE FLOW RATE; VASODILATATION;

EID: 84872400225     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00064.2012     Document Type: Article

References (36)

1. Baggio LL, Drucker DJ. Biology of incretins: GLP-1 and GIP. Gastroenterology 132: 2131-2157, 2007.
2. Brubaker PL. Update on incretin biology: focus on glucagon-like peptide- 1. Endocrinology 151: 1984-1989, 2010.
3. Burcelin R. The incretins: a link between nutrients and well-being. Br J Nutr 93, Suppl 1: S147-S156, 2005.
4. Carpenter RH. Homeostasis: a plea for a unified approach. Adv Physiol Educ 28: 180-187, 2004.
5. Crajoinas RO, Oricchio FT, Pessoa TD, Pacheco BP, Lessa LM, Malnic G, Girardi AC. Mechanisms mediating the diuretic and natriuretic actions of the incretin hormone glucagon-like peptide-1. Am J Physiol Renal Physiol 301: F355-F363, 2011.
6. D'Alessio D, Lu W, Sun W, Zheng S, Yang Q, Seeley R, Woods SC, Tso P. Fasting and postprandial concentrations of GLP-1 in intestinal lymph and portal plasma: evidence for selective release of GLP-1 in the lymph system. Am J Physiol Regul Integr Comp Physiol 293: R2163-R2169, 2007.
7. Deacon CF. What do we know about the secretion and degradation of incretin hormones? Regul Pept 128: 117-124, 2005.
8. Drucker DJ. The biology of incretin hormones. Cell Metab 3: 153-165, 2006.
9. Dumoulin V, Moro F, Barcelo A, Dakka T, Cuber JC. Peptide YY, Glucagon-like peptide-1, and neurotensin responses to luminal factors in the isolated vascularly perfused rat ileum. Endocrinology 139: 3780-3786, 1998.
10. Fehmann HC, Jiang J, Schweinfurth J, Wheeler MG, Boyd AE, Göke G. Stable expression of the rat GLP-I receptor in CHO cells: activation and binding characteristics utilizing GLP-I(7-36)-amide, oxyntomodulin, exendin-4, and exendin(9 -39). Peptides 15: 453-456, 1994.
11. Furman BL. The development of Byetta (exenatide) from the venom of the Gila monster as an anti-diabetic agent. Toxicon 59: 464-471, 2010.
12. Gedulin BR, Smith P, Prickett KS, Tryon M, Barnhill S, Reynolds J, Nielsen LL, Parkes DG, Young AA. Dose-response for glycaemic and metabolic changes 28 days after single injection of long-acting release exenatide in diabetic fatty Zucker rats. Diabetologia 48: 1380-1385, 2005.
13. Girardi AC, Degray BC, Nagy T, Biemesderfer D, Aronson PS. Association of NaH exchanger isoform NHE3 and dipeptidyl peptidase IV in the renal proximal tubule. J Biol Chem 276: 46671-46677, 2001.
14. Gutzwiller JP, Tschopp S, Bock A, Zehnder CE, Huber AR, Kreyenbuehl M, Gutmann H, Drewe J, Henzen C, Goeke B, Beglinger C. Glucagon-like peptide 1 induces natriuresis in healthy subjects and in insulin-resistant obese men. J Clin Endocrinol Metab 89: 3055-3061, 2004.
15. Hirata K, Kume S, Araki S, Sakaguchi M, Chin-Kanasaki M, Isshiki K, Sugimoto T, Nishiyama A, Koya D, Haneda M, Kashiwagi A, Uzu T. Exendin-4 has an anti-hypertensive effect in salt-sensitive mice model. Biochem Biophys Res Commun 380: 44-49, 2009.
16. Klein JD, Blount MA, Sands, JM. Urea transport in the kidney. Compr Physiol 1: 699-729, 2011.
17. Körner M, Stöckli M, Waser B, Reubi JC. GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting. J Nucl Med 48: 736-743, 2007.
18. Lassiter WE, Gottschalk CW, Mylle M. Micropuncture study of net transtubular movement of water and urea in nondiuretic mammalian kidney. Am J Physiol 200: 1139-1146, 1961.
19. Laugero KD, Stonehouse AH, Guss S, Landry J, Vu C, Parkes DG. Exenatide improves hypertension in a rat model of the metabolic syndrome. Metab Syndr Relat Disord 7: 327-334, 2009.
20. Lim GE, Brubaker PL. Glucagon-like peptide 1 secretion by the L-cell. The view from within. Diabetes 55, Suppl 2: S70-S77, 2006.
21. Moreno C, Mistry M, Roman RJ. Renal effects of glucagon-like peptide in rats. Eur J Pharmacol 434: 163-167, 2002.
22. Nowicki S, Opezzo JA, Levin G, Gonzalez D, Elias MM. Furosemide renal excretion rate and the effects of the diuretic on different tubular sites are modified by endogenous dopamine in normohydrated rats. J Pharmacol Exp Ther 274: 1348-1354, 1995.
23. Parkes D, Jodka C, Smith P, Nayak S, Rinehart L, Gingerich R, Chen K, Young A. Pharmacokinetic actions of exendin-4 in the rat: comparison with glucagon-like peptide-1. Drug Dev Res 53: 260-267, 2001.
24. Schlatter P, Beglinger C, Drewe J, Gutmann H. Glucagon-like peptide 1 receptor expression in primary porcine proximal tubular cells. Regul Pept 141: 120-128, 2007.
25. Singh P, Deng A, Blantz RC, Thomson SC. Unexpected effect of angiotensin AT1 receptor blockade on tubuloglomerular feedback in early subtotal nephrectomy. Am J Physiol Renal Physiol 296: F1158-F1165, 2009.
26. Thomson SC, Blantz RC. Glomerulotubular balance, tubuloglomerular feedback, and salt homeostasis. J Am Soc Nephrol 19: 2272-2275, 2008.
27. Thomson SC, Blantz RC. Homeostatic efficiency of tubuloglomerular feedback in hydropenia, euvolemia, and acute volume expansion. Am J Physiol Renal Fluid Electrolyte Physiol 264: F930-F936, 1993.
28. Thomson SC, Blantz RC, Vallon V. Increased tubular flow induces resetting of tubuloglomerular feedback in euvolemic rats. Am J Physiol Renal Fluid Electrolyte Physiol 270: F461-F468, 1996.
29. Thomson Deng A SC, Bao D, Satriano J, Blantz RC, Vallon V. Ornithine decarboxylase, kidney size, and the tubular hypothesis of glomerular hyperfiltration in experimental diabetes. J Clin Invest 107: 217-224, 2001.
30. Thomson SC, Vallon V, Blantz RC. Reduced proximal reabsorption resets tubuloglomerular feedback in euvolemic rats. Am J Physiol Renal Physiol 273: F1414-F1420, 1997.
31. Thomson SC, Rieg T, Miracle C, Mansoury H, Whaley J, Vallon V, Singh P. Acute and chronic effects of SGLT2 blockade on glomerular and tubular function in the early diabetic rat. Am J Physiol Regul Integr Comp Physiol 302: R75-R83, 2012.
32. Tolhurst G, Reimann F, Gribble FM. Nutritional regulation of glucagon- like peptide-1 secretion. J Physiol 587: 27-32, 2009.
33. Viereck C, Boudes P. An analysis of the impact of FDA's guidelines for addressing cardiovascular risk of drugs for type 2 diabetes on clinical development. Contemp Clin Trials 32: 324-332, 2011.
34. Yang J, Campitelli J, Hu G, Lin Y, Luo J, Xue C. Increase in DPP-IV in the intestine, liver and kidney of the rat treated with high fat diet and streptozotocin. Life Sci 81: 272-279, 2007.
35. Yoder SM, Yang Q, Kindel TL, Tso P. Differential responses of the incretin hormones GIP and GLP-1 to increasing doses of dietary carbohydrate but not dietary protein in lean rats. Am J Physiol Gastrointest Liver Physiol 299: G476-G485, 2010.
36. Yu M, Moreno C, Hoagland KM, Dahly A, Ditter K, Mistry M, Roman RJ. Antihypertensive effect of glucagon-like peptide 1 in Dahl salt-sensitive rats. J Hypertens 21: 1125-1135, 2003.